Crescent Capital BDC (CCAP) to Release Earnings on Monday

Crescent Capital BDC (NASDAQ:CCAP) is scheduled to be releasing its earnings data after the market closes on Monday, August 12th. Analysts expect Crescent Capital BDC to post earnings of $0.58 per share for the quarter. Persons interested in registering for the company’s earnings conference call can do so using this link.

Crescent Capital BDC (NASDAQ:CCAP) last posted its quarterly earnings results on Wednesday, May 8th. The company reported $0.63 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.59 by $0.04. The company had revenue of $50.36 million for the quarter, compared to analyst estimates of $48.31 million. Crescent Capital BDC had a net margin of 53.32% and a return on equity of 11.99%. On average, analysts expect Crescent Capital BDC to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Crescent Capital BDC Stock Up 0.3 %

CCAP opened at $17.81 on Friday. Crescent Capital BDC has a 12 month low of $15.03 and a 12 month high of $19.63. The company has a market cap of $660.07 million, a PE ratio of 6.34 and a beta of 0.81. The company has a current ratio of 1.36, a quick ratio of 1.36 and a debt-to-equity ratio of 1.11. The company has a 50 day moving average of $18.77 and a 200 day moving average of $17.70.

Crescent Capital BDC Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, July 15th. Shareholders of record on Friday, June 28th were given a dividend of $0.42 per share. The ex-dividend date of this dividend was Friday, June 28th. This represents a $1.68 annualized dividend and a dividend yield of 9.43%. This is an increase from Crescent Capital BDC’s previous quarterly dividend of $0.41. Crescent Capital BDC’s dividend payout ratio is currently 59.79%.

Analyst Upgrades and Downgrades

CCAP has been the subject of several recent research reports. Wells Fargo & Company lifted their price target on Crescent Capital BDC from $18.00 to $19.00 and gave the company an “equal weight” rating in a research report on Friday, July 26th. Raymond James lifted their target price on Crescent Capital BDC from $18.00 to $19.00 and gave the company an “outperform” rating in a report on Friday, May 10th. Finally, Keefe, Bruyette & Woods upped their price target on Crescent Capital BDC from $18.50 to $19.00 and gave the company an “outperform” rating in a research report on Thursday, May 23rd.

About Crescent Capital BDC

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.